133 related articles for article (PubMed ID: 28266662)
1. Clinical correlates of B-type natriuretic peptide monitoring in outpatients with left ventricular assist device.
Hegarova M; Kubanek M; Netuka I; Maly J; Dorazilova Z; Gazdic T; Franekova J; Lanska V; Melenovsky V; Kautzner J; Malek I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):68-74. PubMed ID: 28266662
[TBL] [Abstract][Full Text] [Related]
2. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.
Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A
Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.
Sareyyupoglu B; Boilson BA; Durham LA; McGregor CG; Daly RC; Redfield MM; Edwards BS; Frantz RP; Pereira NL; Park SJ
ASAIO J; 2010; 56(6):527-31. PubMed ID: 21245799
[TBL] [Abstract][Full Text] [Related]
4. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
5. Value of brain natriuretic peptide after acute myocardial infarction.
Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide-guided therapy and length of hospital stay post left ventricular assist device implantation.
Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Shaukat A; Pickrell J; Caccamo MA; Gradus-Pizlo I; Hadi A
ASAIO J; 2015; 61(2):156-60. PubMed ID: 25485560
[TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
[TBL] [Abstract][Full Text] [Related]
9. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
[TBL] [Abstract][Full Text] [Related]
10. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
Troughton RW; Frampton CM; Yandle TG; Espiner EA; Nicholls MG; Richards AM
Lancet; 2000 Apr; 355(9210):1126-30. PubMed ID: 10791374
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices.
Grosman-Rimon L; Jacobs I; Tumiati LC; McDonald MA; Bar-Ziv SP; Fuks A; Kawajiri H; Lazarte J; Ghashghai A; Shogilev DJ; Cherney DZ; Rao V
Can J Cardiol; 2015 Mar; 31(3):348-56. PubMed ID: 25746024
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device.
Kemperman H; van den Berg M; Kirkels H; de Jonge N
Clin Chem; 2004 Sep; 50(9):1670-2. PubMed ID: 15331503
[No Abstract] [Full Text] [Related]
13. Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.
Medar SS; Hsu DT; Ushay HM; Lamour JM; Cohen HW; Killinger JS
Pediatr Crit Care Med; 2015 Jul; 16(6):529-34. PubMed ID: 25856472
[TBL] [Abstract][Full Text] [Related]
14. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
Kruszewski K; Scott AE; Barclay JL; Small GR; Croal BL; Møller JE; Oh JK; Hillis GS
Am Heart J; 2010 Jan; 159(1):47-54. PubMed ID: 20102866
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
18. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
19. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
[TBL] [Abstract][Full Text] [Related]
20. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]